HomeInsightsDividend

Healthcare Global Enterprises Ltd dividend

Healthcare Global Enterprises Ltd dividend

download
stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

4.9 K

stocks traded

Last Updated time: 20 Jul 9.00 AM

Image

Healthcare Global Enterprises Ltd

NSE: HCG

DPS

--

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Healthcare Global Enterprises Ltd is ₹ 0 as of 2023 .a1#The Dividend Payout of Healthcare Global Enterprises Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#The Latest Trading Price of Healthcare Global Enterprises Ltd is ₹ 348.6 as of 19 Jul 15:30 .a1#The Market Cap of Healthcare Global Enterprises Ltd changed from ₹ 1893 crore on March 2019 to ₹ 3654 crore on March 2023 . This represents a CAGR of 14.05% over 5 years. a1#The Revenue of Healthcare Global Enterprises Ltd changed from ₹ 410.96 crore to ₹ 503.64 crore over 8 quarters. This represents a CAGR of 10.70% a1#The EBITDA of Healthcare Global Enterprises Ltd changed from ₹ 75.07 crore to ₹ 101.04 crore over 8 quarters. This represents a CAGR of 16.01% a1#The Net Pr of Healthcare Global Enterprises Ltd changed from ₹ 2.48 crore to ₹ 23.46 crore over 8 quarters. This represents a CAGR of 207.57% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Healthcare Global Enterprises Ltd

Market Cap

4,857 Cr

EPS

3.3

P/E Ratio (TTM) *

105.0

P/B Ratio (TTM) *

5.9

DTE *

1.5

ROE *

5.8

ROCE *

8.3

Dividend Yield *

0

DPS *

0

Dividend Payout *

0

Ann.Dividend % *

0

* All values are consolidated

Last Updated time: 20 Jul 9.00 AM

* All values are consolidated

Last Updated time: 20 Jul 9.00 AM

×

Historical Dividend Payout of Healthcare Global Enterprises Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Healthcare Global Enterprises Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Healthcare Global Enterprises Ltd

NSE: HCG

PRICE

348.6

-11.35 (-3.15%)

stock direction

Last updated : 19 Jul 15:30

SWOT Analysis Of Healthcare Global Enterprises Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Healthcare Global Enterprises Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Healthcare Global Enterprises Ltd

Period
Mar '191894
Mar '20665
Mar '212395
Mar '223752
Mar '233655

* All values are a in crore

×

Historical Revenue of Healthcare Global Enterprises Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Healthcare Global Enterprises Ltd

Period
Jun '22411
Sep '22422
Dec '22428
Mar '23446
Jun '23463
Sep '23490
Dec '23476
Mar '24504

* All values are a in crore

×

Historical EBITDA of Healthcare Global Enterprises Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Healthcare Global Enterprises Ltd

Period
Jun '2275
Sep '2277
Dec '2279
Mar '2381
Jun '2377
Sep '2388
Dec '2385
Mar '24101

* All values are a in crore

×

Historical Net Profit of Healthcare Global Enterprises Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Healthcare Global Enterprises Ltd

Period
Jun '222
Sep '225
Dec '224
Mar '236
Jun '234
Sep '2311
Dec '233
Mar '2423

* All values are a in crore

About Healthcare Global Enterprises Ltd

About Healthcare Global Enterprises Ltd

    Healthcare Global Enterprises Limited was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a Private Limited Company. The name of the Company was changed to HealthCare Global Enterprises Private Limited on November 14, 2005. Thereafter, it was converted into a Public Limited Company and the name of the Company was changed to Healthcare Global Enterprises Limited on July 5, 2006. Presently, the Company is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector. Under the 'HCG' brand, the Company operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed by the AERB. Under the 'Milann' brand, it operates fertility centres. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. The Milann network also operates on a model similar to our HCG network, wherein the various Milann fertility centres aim to provide medical services following established protocols with a focus on quality medical care across diagnosis and treatment. It provides comprehensive inpatient and outpatient treatments. Its key specialties include cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary and critical care. Healthcare Global Enterprises provides clinical reference laboratory services in India under the Triesta brand with a specialisation in oncology, including molecular diagnostic services and genomic testing. It has Triesta central reference laboratory located in its centre of excellence in Bengaluru. The Triesta central reference laboratory is accredited by NABL in India, as well as by CAP for quality assurance of laboratory tests performed. Additionally, Triesta offers research and development services to pharmaceutical and biotechnology companies in the areas of clinical trial management and biomarker discovery and validation. The company acquired 50.10% equity interest in BACC Healthcare in 2013 which operates fertility centres under the Milann brand, through itself and its wholly-owned subsidiary, DKR Healthcare. HCG EKO Oncology LLP (HCG EKO LLP) HCG EKO LLP was incorporated on May 15, 2015, under the LLP Act as a limited liability partnership firm. HCG EKO LLP is authorised to primarily engage in the business of setting up hospitals at Kolkata with high end linear accelerators, oncology pharmacy and matters incidental and ancillary thereto. HCG (Mauritius) Pvt. Ltd. (HCG Mauritius) was incorporated as a Wholly Owned Subsidiary of the company on May 22, 2015, under the Companies Act, 2001 of Mauritius, as a private limited company. HCG Mauritius is authorised to hold companies which are primarily engaged in the business of treating persons with cancer, carrying on research in the field of oncology and providing various services in the field of oncology. HealthCare Global (Africa) Pvt. Ltd (HCG Africa) was incorporated as a Wholly Owned Subsidiary of the company on May 22, 2015, under the Companies Act, 2001 of Mauritius, as a private limited company. HCG Africa is authorised to engage in the business of treating persons with cancer, carrying on research in the field of oncology and providing various services in the field of oncology and hold companies which are engaged in the same business. Healthcare Global Enterprises entered into a share purchase agreement dated November 23, 2015 with HCG TVH, its erstwhile subsidiary, and Anderson Diagnostics Private Limited. Pursuant to the terms of this agreement, Healthcare Global Enterprises has transferred its entire shareholding in HCG TVH aggregating 51% of the total paid up equity share capital of HCG TVH to Anderson Diagnostics Private Limited for an aggregate consideration of Rs.510,000. Accordingly, HCG TVH has ceased to be the subsidiary of the Company during the Financial Year. During the financial year ended 31 March 2016, Healthcare Global Enterprises transferred its entire shareholding in HealthCare Global (Uganda) Private Limited ('HCG Uganda'), HealthCare Global (Kenya) Private Limited ('HCG Kenya') and HealthCare Global (Tanzania) Private Limited ('HCG Tanzania') to HealthCare Global (Africa) Pvt. Ltd. Accordingly, HCG Uganda, HCG Kenya and HCG Tanzania have become level two subsidiaries of the company. During the year under review, Healthcare Global Enterprises introduced two major latest technologies at some of its centres viz. Robotic Surgery and Tomotherapy Treatment System. Robotic Surgery is an advanced form of minimally invasive or laparoscopic (small incision) surgery, where surgeons use a computer-controlled robot to assist them in certain surgical procedures. This facility was installed at Bangalore and Ahmedabad centres. The TomoTherapy treatment system uses a patented multi-leaf collimator (MLC) that divides the radiation beam into beamlets, all aimed at the tumor. More beam directions give physicians more control in how they plan treatments-and more assurance that dose will be confined to the tumor, reducing the risk of short- and long-term side effects. This facility was installed at Kalinga Rao Road centre, Bangalore. During the financial year ended 31 March 2016, the company completed its Initial Public Offering (IPO) of 29,800,000 equity shares of Rs. 10 each, comprising of Fresh Issue of 11,600,000 equity shares and Offer For Sale of 18,200,000 equity shares at a premium of Rs. 208 per equity share. The total issue size was Rs. 6496.4 million. The IPO was open for subscription during the period from 16 to 18 March 2016. The shares got listed the National Stock Exchange of India Limited and BSE Limited on 30 March 2016. In April 2016, HCG launched its first cancer centre in Visakhapatnam, under its subsidiary company, HCG Pinnacle Oncology Private Limited. HCG Pinnacle Cancer Centre has a capacity of upto 88 beds and provides high quality and comprehensive cancer care services. In May 2016, the company launched its new advanced comprehensive cancer centre in Baroda, under its subsidiary, HCG Oncology LLP. The Centre has a bed capacity of 65 beds and is one of the most advanced in terms of technology in the HCG network. HCG Pinnacle Oncology Private Limited, the wholly owned subsidiary of the Company was merged with the Company effective April 01, 2016. The Company launched the first dedicated comprehensive cancer hospital in Mumbai, in May 2017. In June 2017, HCG launched a comprehensive cancer centre in Nagpur, Maharashtra. The Cancer Care Centre in Kenya, Nairobi was acquired in July, 2017. The Company in April, 2018 acquired 12% equity shares of International Stemcell Services Limited from its existing shareholders. HCG Manavata Cancer Centre, Nashik commenced its operations in May, 2018. The Company sold its entire shareholding in HCG Regency Oncology Healthcare Private Limited to Regency Hospital Limited (RHL) and HCG Regency ceased to be a subsidiary of the Company effective from March 29, 2018. The Company commenced operations of the cancer center in Jaipur in 2018-19. The hospital in Bhavnagar commenced operations as comprehensive cancer center with launch of radiation services in the year 2019. The Nashik center commenced operations of phase 2 with a new building adjoining the original hospital, with advanced Tomotherapy Radiation technology, Bone Marrow transplant facilities and 92 beds. Also, the Company acquired 49.99% stake from its minority partner in Apex HCG Oncology Hospitals LLP, which operates the 1st private cancer center in Mumbai. The Company further commenced operations of 2 day care chemotherapy centers in Bengaluru. It commenced operations at 2 centers in Kolkata and South Mumbai. Milann new center in Ahmedabad, launched in 2018, commenced operations in 2019 and Whitefield center was launched in 2019 in Bengaluru region. The hospital in Kolkata commenced launch of operations as comprehensive cancer center including Bone-Marrow Transplant (BMT) facilities in 2020. South Mumbai center was fully operationalised in FY 2020. In FY 2022, the Company acquired an additional 60.9% in Suchirayu Healthcare Solutions, Hubli, Karnataka, from its existing share of 17.7%, to become a majority stake owner. It also acquired the oncology hospital labs and clinical trial business of Strand Life Sciences through a Business Transfer Agreement (BTA).

Healthcare Global Enterprises Ltd News Hub

News

Healthcare Global Enterprises to convene board meeting

Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company...

Read more

16 May 202415:32

News

Healthcare Global Enterprises to convene board meeting

Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company...

Read more

18 Jan 202410:11

News

Healthcare Global Enterprises announces board meeting date

Healthcare Global Enterprises will hold a meeting of the Board of Directors of the Company...

Read more

28 Oct 202309:31

News

HealthCare Global acquires SRJ CBCC Cancer Hospital

SRJ CBCC Cancer Hospital has 50 cancer care beds and houses state-of-the-art LINAC machine...

Read more

05 Oct 202310:17

News

Healthcare Global Enterprises schedules AGM

Healthcare Global Enterprises announced that the Annual General Meeting (AGM) of the compa...

Read more

01 Sep 202313:44

News

HealthCare Global appoints Ruby Ritolia as CFO

Srinivasa V Raghavan will cease to hold the position of the CFO, with effect from 20 Augus...

Read more

21 Aug 202310:13

FAQs for dividends of Healthcare Global Enterprises Ltd

What is the current market price of Healthcare Global Enterprises Ltd Ltd as of July 20, 2024?

The current market price of Healthcare Global Enterprises Ltd Ltd stands at 348.6 per share.

What dividend did Healthcare Global Enterprises Ltd declare in the last fiscal year?

In the last fiscal year, Healthcare Global Enterprises Ltd declared a dividend totaling ₹0.0.

What is the most recent dividend declared by Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Healthcare Global Enterprises Ltd declared dividends in the current fiscal year

Healthcare Global Enterprises Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Healthcare Global Enterprises Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Healthcare Global Enterprises Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199